{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T10:27:37Z","timestamp":1781000857946,"version":"3.54.1"},"reference-count":37,"publisher":"Georg Thieme Verlag KG","issue":"11","license":[{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research\n            Centre","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"crossref","award":["25901"],"award-info":[{"award-number":["25901"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endosc Int Open"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n          Background and study aims Patients with primary sclerosing cholangitis and\n            inflammatory bowel disease (IBD) have a high risk of colorectal cancer. There is no\n            agreement on the best technique for surveillance for colorectal neoplasia. We aimed to\n            assess whether chromoendoscopy and\/or high-definition endoscopy is associated with\n            increased detection of neoplasia in patients with primary sclerosing cholangitis\n            undergoing surveillance compared with when they were not used.<\/jats:p><jats:p>\n          Patients and methods This was a single-center, retrospective, observational\n            study designed to analyze differences in the detection of neoplasia (adenomatous and\n            serrated) among patients with primary sclerosing cholangitis and IBD who underwent\n            annual surveillance between 2010 and 2020. Multilevel logistic regression was used to\n            adjust for confounders.<\/jats:p><jats:p>\n          Results Ninety-one patients were identified, resulting in 359 colonoscopies with\n            360 person-years of follow up. Over the study period, 22 of 91 patients (24%) had at\n            least one neoplastic lesion identified; however, the mean neoplastic lesion rate was\n            0.87 (54\/63) for the primary sclerosing cholangitis-ulcerative colitis subgroup compared\n            with 0.24 (4\/17) for the primary sclerosing cholangitis-Crohn\u2019s disease subgroup.\n            Chromoendoscopy was associated with a significantly higher detection rate for neoplasia\n            (odds ratio [OR] 5.58, 95% confidence interval [CI] 2.08\u201314.9,P=0.001), and this\n            association remained after adjusting for confounders, including high-definition\n            endoscopy. High-definition endoscopes had a higher rate of neoplasia detection, but the\n            significance was lost after adjustment for confounders, including chromoendoscopy (OR\n            1.93, 95% CI 0.69\u20135.40, P=0.21).<\/jats:p><jats:p>\n          Conclusions Chromoendoscopy is associated with a higher detection rate for\n            neoplasia in patients with primary sclerosing cholangitis and IBD even with\n            high-definition colonoscopes.<\/jats:p>","DOI":"10.1055\/a-2437-8102","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T02:22:22Z","timestamp":1731378142000},"page":"E1285-E1294","source":"Crossref","is-referenced-by-count":3,"title":["Dye-based chromoendoscopy detects more neoplasia than white light endoscopy\n          in patients with primary sclerosing cholangitis and IBD"],"prefix":"10.1055","volume":"12","author":[{"given":"Rodrigo V","family":"Motta","sequence":"first","affiliation":[{"name":"Translational Gastroenterology and Liver Unit, Experimental\n          Medicine Division, Nuffield Department of Medicine, University of Oxford, Oxford, United\n          Kingdom of Great Britain and Northern Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipin","family":"Gupta","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, North Bristol NHS Trust, Bristol,\n          United Kingdom of Great Britain and Northern Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Hartery","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, St James's Hospital, Dublin,\n          Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Bassett","sequence":"additional","affiliation":[{"name":"Statistics, Statsconsultancy Ltd, Buckinghamshire, United Kingdom of Great\n          Britain and Northern Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J","family":"Leedham","sequence":"additional","affiliation":[{"name":"Gastrointestinal Stem Cell Biology Lab, Wellcome Centre Human\n          Genetics, University of Oxford, Oxford, United Kingdom of Great Britain and Northern\n          Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger W","family":"Chapman","sequence":"additional","affiliation":[{"name":"Translational Gastroenterology and Liver Unit, Experimental\n          Medicine Division, Nuffield Department of Medicine, University of Oxford, Oxford, United\n          Kingdom of Great Britain and Northern Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon PL","family":"Travis","sequence":"additional","affiliation":[{"name":"Translational Gastroenterology and Liver Unit, Nuffield\n          Department of Medicine and, Kennedy Institute of Rheumatology, Nuffield Department of\n          Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford,\n          United Kingdom of Great Britain and Northern Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma L","family":"Culver","sequence":"additional","affiliation":[{"name":"Translational Gastroenterology and Liver Unit, Experimental\n          Medicine Division, Nuffield Department of Medicine, University of Oxford, Oxford, United\n          Kingdom of Great Britain and Northern Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"East","sequence":"additional","affiliation":[{"name":"Translational Gastroenterology and Liver Unit, Experimental\n          Medicine Division, Nuffield Department of Medicine, University of Oxford, Oxford, United\n          Kingdom of Great Britain and Northern Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,11,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/MEG.0000000000000576","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis\n          and inflammatory bowel disease: a meta-analysis of 16 observational studies","volume":"28","author":"H-H Zheng","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.cgh.2013.05.017","article-title":"Long-term follow-up reveals low incidence of colorectal cancer, but frequent need for\n          resection, among Australian patients with inflammatory bowel disease","volume":"12","author":"CP Selinger","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MIB.0b013e31828029c0","article-title":"Declining risk of colorectal cancer in inflammatory bowel disease: an updated\n          meta-analysis of population-based cohort studies","volume":"19","author":"MWMD Lutgens","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: a meta-analysis","volume":"48","author":"JA Eaden","year":"2001","journal-title":"Gut"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/j.gastro.2012.04.016","article-title":"Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30\n          years","volume":"143","author":"T Jess","year":"2012","journal-title":"Gastroenterology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/hep.24247","article-title":"Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"53","author":"NA Molodecky","year":"2011","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(19)32545-0","article-title":"Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort\n          study","volume":"395","author":"O Ol\u00e9n","year":"2020","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3748\/wjg.v21.i6.1956","article-title":"Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis","volume":"21","author":"AB de Vries","year":"2015","journal-title":"World J Gastroenterol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5009\/gnl16510","article-title":"Inflammatory bowel disease and primary sclerosing cholangitis: A review of the phenotype\n          and associated specific features","volume":"12","author":"C Palmela","year":"2018","journal-title":"Gut Liver"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.crohns.2011.07.015","article-title":"A unique clinical phenotype of primary sclerosing cholangitis associated with Crohn\u2019s\n          disease","volume":"6","author":"JS Halliday","year":"2012","journal-title":"J Crohns Colitis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cgh.2011.10.020","article-title":"Risk for colorectal neoplasia in patients with colonic Crohn\u2019s disease and concomitant\n          primary sclerosing cholangitis","volume":"10","author":"B Braden","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/MEG.0000000000000576","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis\n          and inflammatory bowel disease: a meta-analysis of 16 observational studies","volume":"28","author":"H-H Zheng","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s41379-019-0419-1","article-title":"Nonconventional dysplasia in patients with inflammatory bowel disease and colorectal\n          carcinoma: a multicenter clinicopathologic study","volume":"33","author":"W-T Choi","year":"2020","journal-title":"Mod Pathol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/ecco-jcc\/jjac090","article-title":"Increased risk of non-conventional and invisible dysplasias in patients with primary\n          sclerosing cholangitis and inflammatory bowel disease","volume":"16","author":"R Zhang","year":"2022","journal-title":"J Crohns Colitis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.cgh.2018.01.023","article-title":"High risk of advanced colorectal neoplasia in patients with primary sclerosing\n          cholangitis associated with inflammatory bowel disease","volume":"16","author":"SC Shah","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/ibd\/izaa205","article-title":"Yield of random biopsies during colonoscopies in inflammatory bowel disease patients\n          undergoing dysplasia surveillance","volume":"27","author":"AB Hu","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1097\/01.pas.0000213313.36306.85","article-title":"Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and\n          KRAS status in serrated polyps and traditional adenomas indicates separate pathways to\n          distinct colorectal carcinoma end points","volume":"30","author":"MJ O\u2019Brien","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis,\n          monitoring of known IBD, detection of complications","volume":"13","author":"C Maaser","year":"2019","journal-title":"J Crohns Colitis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ajg.2018.27","article-title":"ACG Clinical Guideline: Management of Crohn\u2019s Disease in Adults","volume":"113","author":"GR Lichtenstein","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","article-title":"ACG Clinical Guideline: Ulcerative Colitis in Adults","volume":"114","author":"DT Rubin","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1055\/a-1031-7657","article-title":"Advanced imaging for detection and differentiation of colorectal neoplasia: European\n          Society of Gastrointestinal Endoscopy (ESGE) Guideline-Update 2019","volume":"51","author":"R Bisschops","year":"2019","journal-title":"Endoscopy"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/gut.2009.179804","article-title":"Guidelines for colorectal cancer screening and surveillance in moderate and high risk\n          groups (update from 2002)","volume":"59","author":"SR Cairns","year":"2010","journal-title":"Gut"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.gie.2019.04.219","article-title":"Meta-analysis of dye-based chromoendoscopy compared with standard- and high-definition\n          white-light endoscopy in patients with inflammatory bowel disease at increased risk of\n          colon cancer","volume":"90","author":"JD Feuerstein","year":"2019","journal-title":"Gastrointest Endosc"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/gutjnl-2019-319858","article-title":"British Society of Gastroenterology\/Association of Coloproctology of Great Britain and\n          Ireland\/Public Health England post-polypectomy and post-colorectal cancer resection\n          surveillance guidelines","volume":"69","author":"MD Rutter","year":"2020","journal-title":"Gut"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)\n          statement: guidelines for reporting observational studies","volume":"147","author":"E von Elm","year":"2007","journal-title":"Ann Intern Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/den.13521","article-title":"Performance measures in inflammatory bowel disease surveillance colonoscopy:\n          Implementing changes to practice improves performance","volume":"32","author":"SCL Smith","year":"2020","journal-title":"Dig Endosc"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1055\/a-1689-5130","article-title":"Definition of competence standards for optical diagnosis of diminutive colorectal\n          polyps: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement","volume":"54","author":"BBSL Houwen","year":"2022","journal-title":"Endoscopy"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/ecco-jcc\/jjy218","article-title":"Augmented Endoscopy for Surveillance of Colonic Inflammatory Bowel Disease: Systematic\n          Review With Network Meta-analysis","volume":"13","author":"N Imperatore","year":"2019","journal-title":"J Crohns Colitis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1155\/2014\/386540","article-title":"Serrated adenoma prevalence in inflammatory bowel disease surveillance colonoscopy, and\n          characteristics revealed by chromoendoscopy and virtual chromoendoscopy","volume":"28","author":"M Iacucci","year":"2014","journal-title":"Can J Gastroenterol Hepatol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3748\/wjg.v25.i6.659","article-title":"Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and\n          surveillance strategies","volume":"25","author":"BM Fung","year":"2019","journal-title":"World J Gastroenterol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.1007\/s10620-022-07485-w","article-title":"Increased colorectal neoplasia risk in patients with inflammatory bowel disease and\n          serrated polyps with dysplasia","volume":"67","author":"ME de Jong","year":"2022","journal-title":"Dig Dis Sci"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.humpath.2023.05.008","article-title":"Colorectal dysplasia in chronic inflammatory bowel disease: A contemporary consensus\n          classification and interobserver study","volume":"138","author":"N Harpaz","year":"2023","journal-title":"Hum Pathol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.gie.2021.07.024","article-title":"Beyond the SCENIC route: updates in chromoendoscopy and dysplasia screening in patients\n          with inflammatory bowel disease","volume":"95","author":"LG Rabinowitz","year":"2022","journal-title":"Gastrointest Endosc"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1053\/j.gastro.2021.05.063","article-title":"AGA Clinical Practice Update on Endoscopic Surveillance and Management of Colorectal\n          Dysplasia in Inflammatory Bowel Diseases: Expert Review","volume":"161","author":"SK Murthy","year":"2021","journal-title":"Gastroenterology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1055\/a-1031-7657","article-title":"Advanced imaging for detection and differentiation of colorectal neoplasia: European\n          Society of Gastrointestinal Endoscopy (ESGE) Guideline-Update 2019","volume":"51","author":"R Bisschops","year":"2019","journal-title":"Endoscopy"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.igie.2023.03.004","article-title":"Development of an artificial intelligence tool for detecting colorectal lesions in\n          inflammatory bowel disease","volume":"2","author":"D Guerrero Vinsard","year":"2023","journal-title":"iGIE"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"283","DOI":"10.5217\/ir.2023.00020","article-title":"Artificial intelligence in inflammatory bowel disease: implications for clinical\n          practice and future directions","volume":"21","author":"HA Ahmad","year":"2023","journal-title":"Intest Res"}],"container-title":["Endoscopy International Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2437-8102.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T02:22:42Z","timestamp":1731378162000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2437-8102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":37,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11,7]]},"published-print":{"date-parts":[[2024,11]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2437-8102","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2364-3722","2196-9736"],"issn-type":[{"value":"2364-3722","type":"print"},{"value":"2196-9736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11]]}}}